Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Nio Stock Isn’t the ‘Tesla of China’ After All

By Thomas Yeung, CFA, InvestorPlace Markets Analyst
Nio stock rode Tesla's coattails to a 400% gain this year. But there's one problem: Nio isn't the "Tesla of China" after all.

Intel Stock Is a Dud That Can No Longer Keep Up

By InvestorPlace Research Staff
Intel stock lacks attractive qualities and its low valuation is merely a testament to the lack of demand for the stock.

Avoid iBio Stock In the Near-Term As Competitors Keep Racing Ahead

By Ian Cooper, InvestorPlace Contributor
At the moment, it’s better to just avoid iBio stock. There are far better opportunities to be found in this market.

Stay Away From Jumia as Product Quality Worsens

By Chris Lau, InvestorPlace Contributor
Jumia posted a weak outlook ahead because unsatisfied customers are not coming back, suggesting high risks in holding JMIA stock.

Buffett Was Right to Dump His Occidental Petroleum Shares

By David Moadel, InvestorPlace Contributor
With legendary investor Warren Buffett selling oil-market underperformer OXY stock, there's little incentive for anyone else to own it.

Jumia Technologies Is Another Failing Internet Company Investors Should Avoid

By Mark R. Hake, CFA
Jumia Technologies is another failing internet stock to avoid. Jumia will likely continue losing money with little to hope for in JMIA stock.

As Losses Mount, There Are Way Better Buys Than Lemonade Stock

By Mark R. Hake, CFA
Stay away from Lemonade stock as it has no plans to get profitable. Lemonade stock is way too expensive compared with Assurant for it to be considered a bargain investment.

Don’t Be Deceived: There’s No Reason to Speculate on Ocugen

By Chris Markoch, InvestorPlace Contributor
Ocugen continues to conduct at-the-market offerings to raise capital. But with a distant payoff, OCGN stock offers too much risk and not enough reward.

It’s Time to Admit Tilray Stock Isn’t Coming Back and Move On

By David Moadel, InvestorPlace Contributor
If you only listened to CEO Brendan Kennedy's comments, you might feel bullish about Tilray stock, but the data paints a bleaker picture.

Take a Hint from Gold Prices and Run from Wells Fargo Stock

By Josh Enomoto, InvestorPlace Contributor
What many investors need to realize before gambling on Wells Fargo stock is that gold prices are rising. Given that gold is just a commodity, this should clue you in regarding the viability of WFC.

Penny Stock Naked Brand Has Gone From Bad To Worse

By Louis Navellier and the InvestorPlace Research Staff
It can be fun to invest in penny stocks sometimes, but there's no point in owning NAKD stock, which is dirt cheap for a good reason.

FuelCell Investors May Be in for a Very Scary Halloween

By Chris Markoch, InvestorPlace Contributor
FCEL stock has been dropping after a poor earnings report. Unfortunately, FuelCell doesn't have any immediate catalyts in place to reverse its fortunes.

There Are So Many Better Airline Bets Than Debt-Laden American Airlines Stock

By Todd Shriber, InvestorPlace Contributor
Muddying the waters for American and other carriers is the still weak domestic economy. Weekly jobless claims checked in at 884,000 for the week ending Sept. 5, rising for a fourth consecutive week and easily topping economists' forecasts calling for 840,000 claims. Accounting for nearly 839,000 workers filing under the Pandemic Unemployment Assistance Act, the true claims number was 1.69 million.

Luckin Stock: Investors Can Still Get Burned

By Tom Taulli, InvestorPlace Contributor
The company has gone through a terrible accounting scandal. But unfortunately, the impact will likely be long-lasting for Luckin stock.

Luckin Coffee Stock Is Still Looking Terrible

By Lou Carlozo, InvestorPlace Contributor
The Chinese coffee giant defaulted on a major loan and fudged its sales, making Luckin stock untouchable until reform is beyond a doubt.

Sorrento Therapeutics Is An Ailing Investment

By Lou Carlozo, InvestorPlace Contributor
Already in financial distress, SRNE stock has too much riding on a Covid-19 spit test that lags far behind one released by Yale University.

If the FDA Can’t Help Ocugen Stock, You Have to Wonder Who Can

By Tezcan Gecgil, InvestorPlace Contributor
Because of the pandemic, OCGN stock attracts speculative interest. But it is not likely to pay off in the long-run

Avoid General Electric Amid the Current Stock Market Dip

By Bret Kenwell, InvestorPlace Contributor
GE stock doesn't have the fundamentals or the technicals to justify a long position. Ignore this name for now, even amid a marketwide dip.

As iBio Stock Fades, It’s Time to Look Elsewhere for a Vaccine Play

By Tom Taulli, InvestorPlace Contributor
A few months ago, there was lots of optimism for IBIO stock. But unfortunately, the company has not been able to live up to the lofty expectations.
Load More Articles